Stalevo 150 Interactions
There are 497 drugs known to interact with Stalevo 150 (carbidopa/entacapone/levodopa), along with 13 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 46 are major, 439 are moderate, and 12 are minor.
- View all 497 medications that may interact with Stalevo 150
- View Stalevo 150 alcohol/food interactions (2)
- View Stalevo 150 disease interactions (13)
Most frequently checked interactions
View interaction reports for Stalevo 150 (carbidopa / entacapone / levodopa) and the medicines listed below.
- amantadine
- amantadine
- aspirin
- aspirin
- atorvastatin
- atorvastatin
- Azilect (rasagiline)
- Azilect (rasagiline)
- carbidopa / levodopa
- carbidopa / levodopa
- clonazepam
- clonazepam
- gabapentin
- gabapentin
- levothyroxine
- levothyroxine
- lisinopril
- lisinopril
- metformin
- metformin
- MiraLAX (polyethylene glycol 3350)
- MiraLAX (polyethylene glycol 3350)
- omeprazole
- omeprazole
- ropinirole
- ropinirole
- Seroquel (quetiapine)
- Seroquel (quetiapine)
- Sinemet (carbidopa / levodopa)
- Sinemet (carbidopa / levodopa)
Stalevo 150 alcohol/food interactions
There are 2 alcohol/food interactions with Stalevo 150 (carbidopa / entacapone / levodopa).
Stalevo 150 disease interactions
There are 13 disease interactions with Stalevo 150 (carbidopa / entacapone / levodopa) which include:
- glaucoma
- cardiac disease
- hypotension
- neuroleptic malignant syndrome
- psychoses/depression
- psychosis
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- depression
- hepatic impairment
- GI bleeding
More about Stalevo 150 (carbidopa / entacapone / levodopa)
- Stalevo 150 consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: dopaminergic antiparkinsonism agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.